| KALV Stock | | | USD 9.32 0.36 4.02% |
Kalvista Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Kalvista Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kalvista Pharmaceuticals is a good investment. Please check the relationship between Kalvista Pharmaceuticals Accounts Payable and its Capital Surpluse accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Kalvista Stock please use our
How to Invest in Kalvista Pharmaceuticals guide.
Accounts Payable vs Capital Surpluse
Accounts Payable vs Capital Surpluse Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Kalvista Pharmaceuticals Accounts Payable account and
Capital Surpluse. At this time, the significance of the direction appears to have weak relationship.
The correlation between Kalvista Pharmaceuticals' Accounts Payable and Capital Surpluse is 0.39. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Kalvista Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Kalvista Pharmaceuticals' Accounts Payable and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Kalvista Pharmaceuticals are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Accounts Payable i.e., Kalvista Pharmaceuticals' Accounts Payable and Capital Surpluse go up and down completely randomly.
Correlation Coefficient | 0.39 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Accounts Payable
An accounting item on the balance sheet that represents Kalvista Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Kalvista Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Capital Surpluse
Most indicators from Kalvista Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kalvista Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kalvista Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Kalvista Stock please use our
How to Invest in Kalvista Pharmaceuticals guide.
Enterprise Value is likely to climb to about 131.3
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 4.9
M in 2024.
Kalvista Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Kalvista Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kalvista Pharmaceuticals fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to
measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.